These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38058960)

  • 1. Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells.
    Li H; Ji XQ; Zhang SM; Bi RH
    World J Stem Cells; 2023 Nov; 15(11):999-1016. PubMed ID: 38058960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
    Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
    Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconditioning of umbilical cord-derived mesenchymal stem cells by rapamycin increases cell migration and ameliorates liver ischaemia/reperfusion injury in mice via the CXCR4/CXCL12 axis.
    Zheng J; Li H; He L; Huang Y; Cai J; Chen L; Zhou C; Fu H; Lu T; Zhang Y; Yao J; Yang Y
    Cell Prolif; 2019 Mar; 52(2):e12546. PubMed ID: 30537044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice.
    Tu C; Wang Z; Xiang E; Zhang Q; Zhang Y; Wu P; Li C; Wu D
    Curr Stem Cell Res Ther; 2022; 17(6):564-575. PubMed ID: 35086457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted galectin-3 as a possible biomarker for the immunomodulatory potential of human umbilical cord mesenchymal stromal cells.
    Liu GY; Xu Y; Li Y; Wang LH; Liu YJ; Zhu D
    Cytotherapy; 2013 Oct; 15(10):1208-17. PubMed ID: 23850421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms.
    Song Y; Lim JY; Lim T; Im KI; Kim N; Nam YS; Jeon YW; Shin JC; Ko HS; Park IY; Cho SG
    World J Stem Cells; 2020 Sep; 12(9):1032-1049. PubMed ID: 33033563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical Cord-Derived Mesenchymal Stem Cells Are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications.
    Tesarova L; Jaresova K; Simara P; Koutna I
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone priming enhances stemness and immunomodulatory property of tissue-specific human mesenchymal stem cells.
    Rawat S; Dadhwal V; Mohanty S
    BMC Dev Biol; 2021 Nov; 21(1):16. PubMed ID: 34736395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical cord mesenchymal stem cells derived exosomes exert antiapoptosis effect via activating PI3K/Akt/mTOR pathway on H9C2 cells.
    Liu H; Sun X; Gong X; Wang G
    J Cell Biochem; 2019 Sep; 120(9):14455-14464. PubMed ID: 30989714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.
    Ma L; Zhou Z; Zhang D; Yang S; Wang J; Xue F; Yang Y; Yang R
    Thromb Haemost; 2012 May; 107(5):937-50. PubMed ID: 22398715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.
    He H; Takahashi A; Mukai T; Hori A; Narita M; Tojo A; Yang T; Nagamura-Inoue T
    Front Immunol; 2021; 12():686356. PubMed ID: 34484183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
    Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
    Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic preconditioning rejuvenates mesenchymal stem cells and enhances neuroprotection following intracerebral hemorrhage via the miR-326-mediated autophagy.
    Liu J; He J; Ge L; Xiao H; Huang Y; Zeng L; Jiang Z; Lu M; Hu Z
    Stem Cell Res Ther; 2021 Jul; 12(1):413. PubMed ID: 34294127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 modulates immunosuppressive ability and cellular senescence of human umbilical cord mesenchymal stem cells.
    Jie Z; Huan Y; Mengyun W; Yasha L; Huafeng P; Ke Y
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1021-1027. PubMed ID: 32317184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.
    Wang D; Wang S; Huang S; Zhang Z; Yuan X; Feng X; Lu L; Sun L
    Stem Cells Transl Med; 2017 Sep; 6(9):1777-1785. PubMed ID: 28755405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire.
    Davies LC; Queckbörner S; Jylhä CE; Andrén AT; Forshell TZP; Blanc KL
    Cytotherapy; 2023 Sep; 25(9):956-966. PubMed ID: 37354149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells.
    Martinez VG; Ontoria-Oviedo I; Ricardo CP; Harding SE; Sacedon R; Varas A; Zapata A; Sepulveda P; Vicente A
    Stem Cell Res Ther; 2017 Sep; 8(1):208. PubMed ID: 28962641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.